{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T22:45:46Z","timestamp":1694558746774},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,6,27]],"date-time":"2008-06-27T00:00:00Z","timestamp":1214524800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/s11845-008-0167-6","type":"journal-article","created":{"date-parts":[[2008,6,26]],"date-time":"2008-06-26T04:49:41Z","timestamp":1214455781000},"page":"225-231","source":"Crossref","is-referenced-by-count":2,"title":["Invasive pneumococcal disease in children in Ireland\u2014the anticipated benefit of conjugate pneumococcal vaccination"],"prefix":"10.1007","volume":"177","author":[{"given":"J. J.","family":"Fitzsimons","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. L.","family":"Chong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. T.","family":"Cafferkey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. M.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,6,27]]},"reference":[{"key":"167_CR1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1542\/peds.106.2.367","volume":"106","author":"GD Overturf","year":"2000","unstructured":"Overturf GD, the Committee on Infectious Diseases (2000) Technical report: prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis. Pediatrics 106:367\u2013376","journal-title":"Pediatrics"},{"key":"167_CR2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/adc.2003.036921","volume":"89","author":"P Ispahani","year":"2004","unstructured":"Ispahani P, Slack RCB, Donald FE et al (2004) Twenty year surveillance of invasive pneumococcal disease in Nottingham: serogroups responsible and implications for immunisation. Arch Dis Child 89:757\u2013762","journal-title":"Arch Dis Child"},{"key":"167_CR3","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1086\/520286","volume":"26","author":"GD Campbell Jr","year":"1998","unstructured":"Campbell GD Jr, Silberman R (1998) Drug resistant Streptococcus pneumoniae (Review). Clin Infect Dis 26:1188\u20131195","journal-title":"Clin Infect Dis"},{"key":"167_CR4","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1469-0691.2004.00894.x","volume":"10","author":"P Clarke","year":"2004","unstructured":"Clarke P, Murchan S, Smyth EG, Humphreys H (2004) Antimicrobial susceptibility of invasive isolates of Streptococcus pneumoniae in Ireland. Clin Microbiol Infect 10:657\u2013659","journal-title":"Clin Microbiol Infect"},{"key":"167_CR5","unstructured":"http:\/\/www.ndsc.ie\/hpsc\/A-Z\/MicrobiologyAntimicrobialResistance\/EuropeanAntimicrobialResistanceSurveillanceSystemEARSS\/ EARSSSurveillanceReports\/ . Accessed 13 March 2008"},{"key":"167_CR6","unstructured":"http:\/\/www.emea.europa.eu\/humandocs\/Humans\/EPAR\/prevenar\/prevenar.htm . Accessed 13 March 2008"},{"key":"167_CR7","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1086\/313608","volume":"30","author":"WP Hausdorff","year":"2000","unstructured":"Hausdorff WP, Bryant J, Paradiso PR et al (2000) Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part 1. Clin Infect Dis 30:100\u2013121","journal-title":"Clin Infect Dis"},{"key":"167_CR8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1086\/313609","volume":"30","author":"WP Hausdorff","year":"2000","unstructured":"Hausdorff WP, Bryant J, Kloek C et al (2000) The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part 2. Clin Infect Dis 30:122\u2013140","journal-title":"Clin Infect Dis"},{"key":"167_CR9","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00006454-199906000-00015","volume":"18","author":"J Eskola","year":"1999","unstructured":"Eskola J, Anttila M (1999) Pneumococcal conjugate vaccines. Pediatr Infect Dis J 18:543\u2013551","journal-title":"Pediatr Infect Dis J"},{"key":"167_CR10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","volume":"3","author":"S Black","year":"2000","unstructured":"Black S, Shinefield H, Fireman B et al (2000) Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 3:187\u2013195","journal-title":"Pediatr Infect Dis J"},{"key":"167_CR11","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/01.inf.0000157090.40719.9b","volume":"4","author":"RI Haddy","year":"2005","unstructured":"Haddy RI, Perry K, Chacko CE et al (2005) Comparison of incidence of invasive Streptococcus pneumoniae disease among children before and after introduction of conjugated pneumococcal vaccine. Pediatr Infect Dis J 4:320\u2013333","journal-title":"Pediatr Infect Dis J"},{"key":"167_CR12","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1542\/peds.2003-0592-F","volume":"114","author":"KA Poehling","year":"2004","unstructured":"Poehling KA, Lafleur BJ, Szilagyi PG et al (2004) Population-based impact of pneumococcal conjugate vaccine in young children. Pediatrics 114:755\u2013761","journal-title":"Pediatrics"},{"key":"167_CR13","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.294.16.2043","volume":"294","author":"CA Lexau","year":"2005","unstructured":"Lexau CA, Lynfield R, Danila R et al (2005) Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 294:2043\u20132051","journal-title":"JAMA"},{"key":"167_CR14","unstructured":"http:\/\/www.eurosurveillance.org\/ew\/2006\/061207.asp#3 . Accessed 13 March 2008"},{"key":"167_CR15","unstructured":"http:\/\/www.cso.ie\/census\/documents\/vol2_t10_t11_t13.pdf . Accessed 13 March 2008"},{"key":"167_CR16","unstructured":"http:\/\/www.cso.ie\/px\/pxeirestat\/database\/eirestat\/Population.asp . Accessed 13 March 2008"},{"issue":"9260","key":"167_CR17","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0140-6736(00)04222-7","volume":"357","author":"WP Hausdorff","year":"2001","unstructured":"Hausdorff WP, Siber G, Paradiso PR (2001) Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children. Lancet 357(9260):950\u2013952","journal-title":"Lancet"},{"key":"167_CR18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1473-3099(06)70520-5","volume":"7","author":"T Jefferson","year":"2006","unstructured":"Jefferson T, Ferroni E, Curtale F et al (2006) Streptococcus pneumoniae in western Europe: serotype distribution and incidence in children less than 2\u00a0years old. Lancet Infect Dis 7:405\u2013410","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"167_CR19","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/adc.86.6.403","volume":"86","author":"ED McIntosh","year":"2002","unstructured":"McIntosh ED, Booy R (2002) Invasive pneumococcal disease in England and Wales: what is the true burden and what is the potential for prevention using 7 valent pneumococcal conjugate vaccine? Arch Dis Child 86(6):403\u2013406","journal-title":"Arch Dis Child"},{"issue":"23","key":"167_CR20","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1001\/jama.1992.03490230053027","volume":"268","author":"J Eskola","year":"1992","unstructured":"Eskola J, Takala AK, Kela E et al (1992) Epidemiology of invasive pneumococcal infections in children in Finland. JAMA 268(23):3323\u20133327","journal-title":"JAMA"},{"issue":"5","key":"167_CR21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1440-1754.2002.00035.x","volume":"38","author":"DJ Christie","year":"2002","unstructured":"Christie DJ, Coleman DJ, Wan X et al (2002) Childhood invasive pneumococcal disease in Tasmania, 1994\u20132000. J Paediatr Child Health 38(5):445\u2013449","journal-title":"J Paediatr Child Health"},{"issue":"11","key":"167_CR22","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1097\/00006454-200111000-00005","volume":"20","author":"T Juven","year":"2001","unstructured":"Juven T, Mertsola J, Toikka P, Virkki R, Leinonen M, Ruuskanen O (2001) Clinical profile of serologically diagnosed pneumococcal pneumonia. Pediatr Infect Dis J 20(11):1028\u20131033","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"167_CR23","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/00006454-200209000-00005","volume":"21","author":"SB Black","year":"2002","unstructured":"Black SB, Shinefield HR, Ling S et al (2002) Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J 21(9):810\u2013815","journal-title":"Pediatr Infect Dis J"},{"key":"167_CR24","unstructured":"http:\/\/www.esri.ie\/health_information\/hipe\/ . Accessed 13 March 2008"},{"key":"167_CR25","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1017\/S0950268806007199","volume":"135","author":"ED McIntosh","year":"2006","unstructured":"McIntosh ED, Fritzell B, Fletcher MA (2006) Burden of paediatric invasive pneumococcal disease in Europe, 2005. Epidemiol Infect 135:644\u2013656","journal-title":"Epidemiol Infect"},{"key":"167_CR26","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1007\/s00431-002-1064-z","volume":"161","author":"S Black","year":"2002","unstructured":"Black S, Shinefield H (2002) Safety and efficacy of the seven-valent pneumococcal conjugate vaccine: evidence from Northern California. Eur J Pediatr 161:S127\u2013S131","journal-title":"Eur J Pediatr"},{"issue":"14","key":"167_CR27","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJMoa051642","volume":"354","author":"MH Kyaw","year":"2006","unstructured":"Kyaw MH, Lynfield R, Schaffner W et al (2006) Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 354(14):1455\u20131463","journal-title":"N Engl J Med"},{"issue":"14","key":"167_CR28","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJMe068038","volume":"354","author":"DM Musher","year":"2006","unstructured":"Musher DM (2006) Pneumococcal vaccine\u2014direct and indirect (\u201cherd\u201d) effects. N Engl J Med 354(14):1522\u20131524","journal-title":"N Engl J Med"},{"issue":"14","key":"167_CR29","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.vaccine.2004.08.051","volume":"23","author":"ED McIntosh","year":"2005","unstructured":"McIntosh ED, Conway P, Willingham J et al (2005) Pneumococcal pneumonia in the UK\u2014how herd immunity affects the cost-effectiveness of 7-valent pneumococcal conjugate vaccine (PCV). Vaccine 23(14):1739\u20131745","journal-title":"Vaccine"},{"issue":"1","key":"167_CR30","first-page":"95","volume":"355","author":"P Kopterides","year":"2000","unstructured":"Kopterides P, Falagas ME (2000) Potential consequences of the pneumococcal conjugate vaccine. N Engl J Med 355(1):95; author reply 95\u201396","journal-title":"N Engl J Med"},{"key":"167_CR31","doi-asserted-by":"crossref","first-page":"e408","DOI":"10.1542\/peds.2004-2338","volume":"116","author":"SS Huang","year":"2005","unstructured":"Huang SS, Platt R, Rifas-Shiman SL et al (2005) Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics 116:e408\u2013e413","journal-title":"Pediatrics"},{"issue":"6","key":"167_CR32","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/INF.0b013e31805cdbeb","volume":"26","author":"AF Messina","year":"2007","unstructured":"Messina AF, Katz-Gaynor K, Barton T et al (2007) Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005. Pediatr Infect Dis J 26(6):461\u2013467","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"167_CR33","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2807\/esm.11.09.00646-en","volume":"11","author":"RG Pebody","year":"2006","unstructured":"Pebody RG, Hellenbrand W, D\u2019Ancona F et al (2006) Pneumococcal disease surveillance in Europe. Euro Surveill 11(9):171\u2013178","journal-title":"Euro Surveill"},{"issue":"2","key":"167_CR34","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01.inf.0000151022.92222.be","volume":"24","author":"H Kayhty","year":"2005","unstructured":"Kayhty H, Ahman H, Eriksson K et al (2005) Immunogenicity and tolerability of a heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 12\u00a0months of age. Pediatr Infect Dis J 24(2):108\u2013114","journal-title":"Pediatr Infect Dis J"}],"container-title":["Irish Journal of Medical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-008-0167-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11845-008-0167-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-008-0167-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T19:09:22Z","timestamp":1559416162000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11845-008-0167-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,27]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["167"],"URL":"https:\/\/doi.org\/10.1007\/s11845-008-0167-6","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,27]]}}}